Related Experiment Video
Updated: Jan 9, 2026

Comparing Bibliometric Analysis Using PubMed, Scopus, and Web of Science Databases
Published on: October 24, 2019
Fifty Years of Retracted Medical Publications From 1975 to 2024: A Comprehensive Analysis of Trends, Reasons, and
Ramazan Azim Okyay1, Burhan Fatih Kocyigit2, Ainur B Qumar3
1Department of Public Health, Faculty of Medicine, Kahramanmaraş Sütçü İmam University, Kahramanmaraş, Türkiye.
Background:
Scientific medical research has progressed tremendously during the last 50 years, but concerns about research integrity, publishing ethics, and retraction trends have grown. Retractions are essential for revising the scientific record and maintaining credibility, yet an extensive long-term assessment of retracted medical publications is limited.
Methods:
We performed a descriptive analysis of 50 years of retracted medical publications from the Retraction Watch Database. Data were refined to encompass solely medicine-related retractions, omitting corrections, expressions of concern, and reinstatements. We classified retraction reasons into 68 categories, emphasizing the top 10 most frequently encountered reasons. Temporal trends were evaluated employing semi-logarithmic linear regression models. The geographical distribution and journal-specific retractions were also examined.
Results:
An analysis was conducted on 16,041 retracted medical documents from 1975 to 2024. The leading reasons for retraction included data concerns (31.47%), fraud (11.37%), peer review issues (11.21%), referencing issues (7.54%), and ethical violations (7.09%). The highest number of retractions was noted in Computational and Mathematical Methods in Medicine (5.91%), Journal of Healthcare Engineering (5.85%), and Evidence-Based Complementary and Alternative Medicine (4.36%). Approximately 45.28% of retracted papers included at least one author from China, followed by the United States and India. The medical subfields most impacted were oncology (19.87%), cardiovascular medicine (15.62%), and pharmacology (14.49%). Temporal analysis indicated a steady rise in retractions, with data concerns and fraud doubling typically every 5.5 and 5.2 years.
Conclusion:
The rising amount of retractions underscores heightened scrutiny and enhanced detection techniques while highlighting ongoing research integrity issues. Data integrity, fraudulent activities, and compromised peer review are significant issues. Fortifying editorial policies, augmenting transparency, and bolstering research ethics education are essential for reducing misconduct and maintaining the integrity of medical papers.
More Related Videos
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Clot Retraction and Fibrinolysis
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Therapeutic Drug Monitoring: Affecting Factors
Clinical Trials
There are four phases in a clinical trial. A phase one...

